Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.7.7.6 (
RNA polymerase
)
34,946
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
We previously identified a novel TATA-binding protein (TBP)-interacting protein (
TIP120
) from the rat liver. Here, in an
RNA polymerase II
(RNAP II)-reconstituted transcription system, we demonstrate that recombinant
TIP120
activates the basal level of transcription from various kinds of promoters regardless of the template DNA topology and the presence of TFIIE/TFIIH and TBP-associated factors. Deletion analysis demonstrated that a 412-residue N-terminal domain, which includes an acidic region and the TBP-binding domain, is required for
TIP120
function. Kinetic studies suggest that
TIP120
functions during preinitiation complex (PIC) formation at the step of RNAP II/TFIIF recruitment to the promoter but not after the completion of PIC formation. Electrophoretic mobility shift assays showed that
TIP120
enhanced PIC formation, and
TIP120
also stimulated the nonspecific transcription and DNA-binding activity of RNAP II. These lines of evidence suggest that
TIP120
is able to activate basal transcription by overcoming a kinetic impediment to RNAP II/TFIIF integration into the TBP (TFIID)-TFIIB-DNA-complex. Interestingly,
TIP120
also stimulates RNAP I- and III-driven transcription and binds to RPB5, one of the common subunits of the eukaryotic RNA polymerases, in vitro. Furthermore, in mouse cells, ectopically expressed
TIP120
enhances transcription from all three classes (I, II, and III) of promoters. We propose that
TIP120
globally regulates transcription through interaction with basal transcription mechanisms common to all three transcription systems.
...
PMID:TATA-Binding protein-interacting protein 120, TIP120, stimulates three classes of eukaryotic transcription via a unique mechanism. 1056 21